THE ANTI-HEPCIDIN SPIEGELMER® LEXAPTEPID PEGOL (NOX-H94) AS TREATMENT OF ANEMIA OF CHRONIC DISEASE IN PATIENTS WITH MULTIPLE MYELOMA, LOW GRADE LYMPHOMA, AND CLL: A PHASE II PILOT STUDY
EHA Library, Kai Riecke,
54472
IMPROVEMENTS IN HEMOGLOBIN LEVELS AND FATIGUE IN A RANDOMIZED, DOUBLE BLINDED, PLACEBO CONTROLLED STUDY (MCD3282001) OF SILTUXIMAB IN PATIENTS WITH MULTICENTRIC CASTLEMAN'S DISEASE (MCD)
EHA Library, Frits van Rhee,
54509
INFLAMMATORY AND ANEMIA-RELATED MARKERS IN A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF SILTUXIMAB (ANTI-IL-6 MONOCLONAL ANTIBODY) IN MULTICENTRIC CASTLEMAN\'S DISEASE PATIENTS
EHA Library, Corey Casper,
54511